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Introduction {#sec1}
============

Inflammasomes are cytosolic protein platforms with important roles in host-pathogen interactions, and mutations in several inflammasome components have been shown to predispose to chronic inflammatory diseases ([@bib24], [@bib49]). Inflammasomes have long been recognized to contribute to inflammatory outcomes by promoting caspase-1-mediated maturation of the inflammatory cytokines interleukin (IL)-1β and IL-18. Activation of inflammatory caspase-1 and caspase-11 also triggers pyroptosis, which is a lytic cell death mode that has been characterized primarily in cells of the myeloid lineage ([@bib15], [@bib52]). Pyroptosis is increasingly regarded as a mechanism that contributes importantly to the host's ability to clear infections. It promotes passive release of the inflammasome-dependent cytokines IL-1β and IL-18 along with danger-associated molecular patterns (DAMPs), such as HMGB1, to attract and stimulate secondary immune cells at the infected tissue ([@bib14], [@bib19], [@bib28]). Pyroptosis is also thought to trap bacteria inside the pyroptotic cell corpse, which has been coined the "pyroptotic intracellular trap," as a mechanism to counter pathogen spreading and to facilitate efferocytosis by infiltrating neutrophils ([@bib16]). Although its roles in chronic inflammatory diseases remain to be characterized, it is likely that pyroptosis contributes to detrimental inflammation and tissue destruction in this context. Thus, a better understanding of inflammasome-induced cell death regulation may reveal cell death checkpoints for altering the course of life-threatening infections and chronic inflammatory pathologies.

Notably, several studies have shown that pyroptosis induction by the Pyrin domain (PYD)-based NLRP3, AIM2, and Pyrin inflammasomes requires the inflammasome adaptor ASC ([@bib33], [@bib57]), and ASC has also been shown to induce caspase-8 activation and apoptosis in caspase-1-deficient macrophages that have been stimulated with NLRP3 and AIM2 agonists ([@bib39], [@bib43]). Contrastingly, ASC is dispensable for induction of pyroptosis by the CARD-based inflammasome sensors NLRP1b and NLRC4, which may recruit caspase-1 directly through CARD-CARD interactions ([@bib4], [@bib12], [@bib33], [@bib51]). Accordingly, anthrax lethal toxin (LeTx)-elicited pyroptosis was unchanged in ASC-deficient macrophages ([@bib51]). ASC was also not needed for NLRC4- and caspase-1-dependent pyroptosis of *Salmonella enterica* serovar Typhimurium (*S*. Typhimurium)-infected macrophages, although it did contribute to efficient IL-1β secretion and caspase-1 maturation under these conditions ([@bib4], [@bib12], [@bib33], [@bib51]). Other work established that caspase-8 co-localizes with caspase-1 in ASC specks of wild-type macrophages infected with *Salmonella* (*S.*) Typhimurium, although caspase-8 proved to be dispensable for *S.* Typhimurium-induced pyroptosis ([@bib32]). NLRC4 and ASC have also been shown recently to promote caspase-8 activation to induce gasdermin D-independent cell lysis of *Legionella pneumophila*-infected macrophages that were deficient for caspase-1 and caspase-11 ([@bib35]). However, the role of caspase-8 in NLRP1b- and NLRC4-induced apoptosis and the regulatory mechanisms that control apoptosis induction by inflammasome sensors are largely unknown.

Here we showed that NLRP1b and NLRC4 induce apoptosis as an alternative cell death program in *caspase-1*^*−/−*^ macrophages and intestinal epithelial organoids that requires ASC and caspase-8. Moreover, we delineated critical mechanisms that regulate caspase-8 activation and apoptosis induction by these CARD-based inflammasome sensors. Overall, this work suggests re-routing pyroptosis toward ASC- and caspase-8-dependent apoptosis as a paradigm for suppressing inflammation.

Results {#sec2}
=======

Anthrax LeTx Induces Caspase-8-Dependent Apoptosis of Caspase-1-Deficient Macrophages {#sec2.1}
-------------------------------------------------------------------------------------

Anthrax LeTx induces ASC-independent pyroptosis in macrophages expressing a functional *NLRP1b* allele ([@bib12], [@bib51]). To study the role of ASC specks in the absence of confounding induction of pyroptosis, we bred C57BL/6J (*B6*) mice that express a functional Nlrp1b transgene (*B6*^*Nlrp1b+*^) to mice lacking caspase-1 and caspase-11 (*B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^). As a complementary approach, *C1*^*−/−*^*C11*^*−/−*^ mice were backcrossed to the BALB/c genetic background (*BALB/c-C1*^*−/−*^*C11*^*−/−*^), which encodes a functional *NLRP1b* allele and is naturally susceptible to LeTx-induced inflammasome activation ([@bib2], [@bib51]). Consistent with defective pyroptosis induction in *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages, culture supernatants of LeTx-treated *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ bone marrow-derived macrophages (BMDMs) lacked lactate dehydrogenase (LDH) activity, unlike caspase-1-sufficient *B6*^*Nlrp1b+*^ macrophages that had been exposed to LeTx ([Figure 1](#fig1){ref-type="fig"}A). Rather than being protected from cell death, however, microscopic analysis of LeTx-treated *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages revealed these cells to display hallmark features of apoptosis, including cell shrinkage, nuclear condensation, and formation of membrane blebs and apoptotic bodies ([Figure 1](#fig1){ref-type="fig"}B). Fluorescence-activated cell sorting (FACS) analysis of annexin V (which binds to phosphatidylserine) and propidium iodide (PI) (a membrane-impermeant DNA-intercalating agent) staining confirmed cell death induction in LeTx-treated *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages, with both *B6*^*Nlrp1b+*^ and *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages displaying approximately 90% annexin V positivity 3 hr after LeTx treatment ([Figures 1](#fig1){ref-type="fig"}C and 1D). Microscopic analysis of *BALB/c-C1*^*−/−*^*C11*^*−/−*^ macrophages confirmed the appearance of an apoptotic morphology after intoxication with LeTx akin to our results in *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages ([Figure 1](#fig1){ref-type="fig"}E). In contrast, the morphology of LeTx-treated wild-type *BALB/c* macrophages (which express a functional NLRP1b and caspase-1) was characterized by features of pyroptosis, including cell rounding and swollen nuclei. Together, these results suggest that caspase-1 ablation converts LeTx-induced pyroptosis into apoptosis.Figure 1LeTx Triggers Caspase-8 Activation and Apoptosis in Caspase-1-Deficient Macrophages(A--D) *B6*^*Nlrp1b+*^ and *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ BMDMs were treated with LeTx for 3 hr before supernatants were analyzed for LDH activity (A), bright-field images were acquired (B), and cells were stained for annexin V and PI followed by FACS analysis (C) and quanitification of annexin V-positive cells (D).(E and H) Wild-type and caspase-1/11-deficient *BALB*/*c* BMDMs were stimulated with LeTx for 3 hr and then microscopically analyzed (E), and lysates were immunoblotted for caspase-1 and caspase-8 (H).(F and G) BMDM lysates of the indicated genotypes were immunoblotted for RIPK3 and RIPK1 (F) and caspase- 1 and caspase-8 (G) following LeTx-treatment for the indicated durations.(I--K) z-IETD-fmk-pretreated *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ BMDMs were stimulated with LeTx for 3 hr before lysates were immunoblotted for caspase-8 (I). Cells were analyzed by FACS (J) and annexin V-positive cells (K) were quantified in parallel.(L and M) BMDMs were incubated with TAT-CrmA for 10 min, followed by LeTx for 3 hr, before lysates were immunoblotted for caspase-1 and caspase-8 (L), and bright-field images were acquired (M).All scale bars are set at 20 μm. All data are representative of results from three independent experiments. Data are shown as mean ± SD from a single representative experiment of at least three independent experiments, with each condition performed in triplicate.

Caspase-8 is the key initiator caspase that triggers apoptosis in the context of death receptor-induced apoptosis, and proteolysis of RIPK1 and RIPK3 is a biochemical hallmark of death receptor-induced caspase-8 activation ([@bib7], [@bib34]). We hypothesized that caspase-8 activation would induce similar RIPK1 and RIPK3 cleavage in LeTx-treated apoptotic macrophages. In agreement, we observed a significant accumulation of RIPK1 and RIPK3 cleavage fragments as early as 90 min after LeTx treatment in apoptotic but not pyroptotic macrophages ([Figure 1](#fig1){ref-type="fig"}F). The detection of significant levels of procaspase-8 maturation in apoptotic *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ ([Figure 1](#fig1){ref-type="fig"}G) and *BALB/c-C1*^*−/−*^*C11*^*−/−*^ macrophages ([Figure 1](#fig1){ref-type="fig"}H) further supported this notion. Notably, weak maturation of procaspase-8 was observed in pyroptotic macrophages, in agreement with published reports ([@bib13], [@bib32]). The kinetics of caspase-8 maturation in apoptotic *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages was akin to that of caspase-1 in pyroptotic *B6*^*Nlrp1b+*^ cells, with both being clearly detected 2 hr post-LeTx treatment ([Figure 1](#fig1){ref-type="fig"}G). Similar results were obtained when comparing caspase-1-sufficient *BALB/c* macrophages with caspase-1-deficient cells ([Figure 1](#fig1){ref-type="fig"}H). Because caspase-8-deficient mice are embryonically lethal ([@bib53]), and caspase-8 is required for macrophage differentiation ([@bib13], [@bib17]), we initially took advantage of the peptidomimetic caspase-8 inhibitor benzyloxycarbonyl-Ile-Glu(OMe)-Thr-Asp(OMe)-fluoromethylketone (z-IETD-fmk) to further characterize the role of caspase-8 in LeTx-induced apoptosis. This inhibitor significantly inhibited (but did not abolish) caspase-8 maturation in LeTx-treated *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages ([Figure 1](#fig1){ref-type="fig"}I), which corresponded with a 50% reduction in annexin V-positive cells ([Figures 1](#fig1){ref-type="fig"}J and 1K). Consistently, caspase-8-targeting small interfering RNAs (siRNAs) significantly reduced procaspase-8 expression levels in naive macrophages to about half of those of scrambled control siRNA-treated cells ([Figure S1](#mmc1){ref-type="supplementary-material"}A). This corresponded with important reductions in caspase-3 activity, as measured by Asp-Glu-Val-Asp-ase (DEVD-ase) assay ([Figure S1](#mmc1){ref-type="supplementary-material"}B), and caspase-8 and caspase-3 maturation levels ([Figure S1](#mmc1){ref-type="supplementary-material"}C) in LeTx-treated *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages. Moreover, the selective poxvirus-encoded caspase-1/8 inhibitor cytokine response modifier (CrmA) provided marked inhibition of caspase-8 maturation ([Figure 1](#fig1){ref-type="fig"}L) and apoptosis induction ([Figure 1](#fig1){ref-type="fig"}M) in *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages. Overall, these results establish caspase-8 as a major driver of LeTx-induced apoptosis.

NLRP1b and ASC Specks Are Required for LeTx-Induced Caspase-8 Activation and Apoptosis {#sec2.2}
--------------------------------------------------------------------------------------

We next set out to investigate the mechanism of LeTx-induced caspase-8 maturation and apoptosis induction. The requirement for NLRP1b was addressed by comparing apoptotic responses in caspase-1/11-deficient macrophages that are sufficient (*B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^) or deficient (*C1*^*−/−*^*C11*^*−/−*^) for a functional *Nlrp1b* allele, respectively. Consistent with our earlier findings, *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages efficiently activated caspase-8 and the apoptotic effector caspase-3 within 2 hr post-LeTx exposure ([Figure 2](#fig2){ref-type="fig"}A). Contrastingly, the absence of a functional *Nlrp1b* allele prevented maturation of caspase-3 and caspase-8 in LeTx-exposed *C1*^*−/−*^*C11*^*−/−*^ macrophages ([Figure 2](#fig2){ref-type="fig"}A) and rendered these cells resistant to apoptosis induction ([Figure 2](#fig2){ref-type="fig"}B). As reported previously ([@bib9], [@bib51]), the protease activity of LeTx was necessary for NLRP1b-mediated caspase-1 maturation and pyroptosis induction in *B6*^*Nlrp1b+*^ macrophages ([Figures 2](#fig2){ref-type="fig"}C and 2D). LeTx metalloprotease activity was also required for apoptosis induction because the catalytically inactive LF~E687C~ mutant failed to activate caspase-8 ([Figure 2](#fig2){ref-type="fig"}C) and induce apoptosis ([Figure 2](#fig2){ref-type="fig"}D) in *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages. The 26S proteasome inhibitor MG132 was shown previously to inhibit LeTx-induced caspase-1 activation in the J774A.1 cell line ([@bib47]), and we extended this observation by demonstrating inhibition of caspase-1 and pyroptosis in primary *B6*^*Nlrp1b+*^ macrophages ([Figure 2](#fig2){ref-type="fig"}E; [Figure S2](#mmc1){ref-type="supplementary-material"}A). Moreover, MG132 blocked caspase-8 activation and apoptosis in *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages ([Figure 2](#fig2){ref-type="fig"}E; [Figure S2](#mmc1){ref-type="supplementary-material"}A). As a control, MG132 did not interfere with the protease activities of LeTx, caspase-1, and caspase-8 ([Figures S2](#mmc1){ref-type="supplementary-material"}B--S2D), suggesting that the proteasome is selectively required upstream of NLRP1b for LeTx-induced pyroptosis and apoptosis. In conclusion, these results suggest that the apoptotic and pyroptotic signaling pathways upstream of NLRP1b are conserved.Figure 2NLRP1b and ASC Are Required for LeTx-Induced Caspase-8 Activation and Apoptosis(A and B) BMDMs were treated with LeTx for the indicated durations before lysates were immunoblotted for caspase-8 and caspase-3 (A). Bright-field images were taken 3 hr after LeTx stimulation (scale bar, 20 μm) (B).(C and D) BMDMs were stimulated with PA and LF or the catalytic LF~E687C~ mutant before lysates were immunoblotted for caspase11 and caspase-8 (C), and bright-field images were acquired (scale bar, 20 μm) (D).(E) BMDMs were treated with MG132 followed by LeTx before lysates were immunoblotted for caspase-1 and caspase-8.(F--H) Crosslinked ASC oligomers were isolated from BMDMs following LeTx stimulation, and lysates were immunoblotted for ASC (F).(G and H) ASC specks were quantified over multiple representative confocal micrographs depicting DAPI (blue), caspase-8 (green), and ASC (red) staining (scale bar, 10 μm) (G). Representative images are shown (H).(I--K) BMDMs of the indicated genotypes were stimulated with LeTx before lysates were immunoblotted for caspase-1 and caspase-8 and ASC (I). Confocal images were acquired for DAPI (blue), caspase-8 (green), and ASC (red) (scale bar, 10 μm) (J), and bright-field images were taken (scale bar, 20 μm) (K).All results are representative of at least three independent experiments, and data are shown as mean ± SD from a single representative experiment.

Based on these results, we then sought to address the role of ASC in LeTx-induced apoptosis. To this end, we first investigated whether ASC specks are formed in apoptotic *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages. Both biochemical ([Figure 2](#fig2){ref-type="fig"}F) and microscopic ([Figures 2](#fig2){ref-type="fig"}G and 2H) analysis confirmed significantly more ASC specks being formed during LeTx-induced apoptosis compared with pyroptotic cells. Notably, an antibody specific for active caspase-8 weakly stained ASC specks in pyroptotic cells ([Figure 2](#fig2){ref-type="fig"}H), consistent with reported observations of caspase-8 recruitment to the NLRP3 ([@bib13], [@bib43]), NLRC4 ([@bib32]), and AIM2 ([@bib39]) inflammasomes in cells undergoing pyroptosis. Relative to pyroptotic cells, however, active caspase-8 staining in apoptotic *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages was markedly increased, and active caspase-8 was readily detected both within and outside of ASC specks during apoptosis ([Figure 2](#fig2){ref-type="fig"}H). Moreover, MG132 pretreatment blocked NLRP1b-mediated caspase-8 activation and ASC speck formation ([Figure S2](#mmc1){ref-type="supplementary-material"}E), consistent with the 26S proteasome acting upstream of NLRP1b and ASC speck assembly. These results prompted us to delete ASC to dissect its contribution to caspase-8 activation during LeTx-induced apoptosis. Remarkably, ASC deletion in *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages abolished LeTx-induced caspase-8 maturation, as evidenced by western blotting ([Figure 2](#fig2){ref-type="fig"}I) and immunostaining ([Figure 2](#fig2){ref-type="fig"}J) for active caspase-8. We previously showed that ASC was dispensable for LeTx-induced pyroptosis ([@bib51]), but, contrastingly, ASC deletion rendered *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages fully resistant to LeTx-induced apoptosis ([Figure 2](#fig2){ref-type="fig"}K). These results suggest that NLRP1b induces pyroptosis and apoptosis from different cytosolic platforms: ASC-independent NLRP1b inflammasomes engage caspase-1 directly for pyroptosis, whereas NLRP1b-induced caspase-8 activation and apoptosis originate from ASC specks.

NLRC4 Induces ASC- and Caspase-8-Mediated Apoptosis in *Caspase-1*^*−/−*^ Macrophages and Intestinal Epithelial Cell Organoids {#sec2.3}
------------------------------------------------------------------------------------------------------------------------------

Akin to NLRP1b, NLRC4 contains a CARD that allows it to recruit caspase-1 directly and induce pyroptosis independently of ASC ([@bib4], [@bib51]). The NAIP5/NLRC4 inflammasome can be engaged by Streptolysin O (SLO)-mediated delivery of recombinant *S*. Typhimurium flagellin into the cytosol of macrophages ([@bib25]). As expected, cytosolic flagellin triggered pyroptosis in *B6*^*Nlrp1b+*^ macrophages ([Figure 3](#fig3){ref-type="fig"}A). However, *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages responded with apoptosis, suggesting that agonists of the NAIP5/NLRC4 inflammasome activate caspase-8 when caspase-1 engagement fails. Paralleling our earlier results with NLRP1b, apoptosis induction by the NAIP5/NLRC4 inflammasome was abolished by further deletion of ASC in *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages ([Figure 3](#fig3){ref-type="fig"}A). Consistent with flagellin-induced apoptosis being ASC- and caspase-8-dependent, we observed efficient caspase-8 maturation in *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ BMDMs, which was abolished in congenic cells lacking ASC ([Figure 3](#fig3){ref-type="fig"}B). Notably, pyroptosis induction in flagellin-treated *B6*^*Nlrp1b+*^ macrophages was associated with weak caspase-8 maturation concomitant with efficient caspase-1 cleavage ([Figure 3](#fig3){ref-type="fig"}B), consistent with a previous report showing co-localization of caspases 1 and 8 in ASC specks of *S*. Typhimurium-infected B6 macrophages ([@bib32]). NAIP5/NLRC4 inflammasome-dependent pyroptosis can also be induced by stimulating macrophages with *B. anthracis* protective antigen (PA) in the presence of a chimeric fusion protein that consists of *Legionella pneumophila* flagellin (FlaA) and the N-terminal domain of *B. anthracis* lethal factor (LF) ([@bib56]). As with SLO-mediated delivery of recombinant *S.* Typhimurium flagellin, stimulation with PA + LFn-FlaA (hereafter called FlaTox) triggered pyroptosis in *B6*^*Nlrp1b+*^ BMDMs, whereas ASC/caspase-8-mediated apoptosis was induced in *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ BMDMs (data not shown). Akin to LeTx-induced apoptosis in macrophages of the latter genotype ([Figure 2](#fig2){ref-type="fig"}J), FlaTox-induced apoptosis was accompanied by abundant ASC speck assembly ([Figure 3](#fig3){ref-type="fig"}C). Notably, the bipartite death domain (DD)/death effector domain (DED) adaptor protein FADD also accumulated in ASC specks, suggesting that FADD bridges the interaction between ASC and caspase-8 ([Figure 3](#fig3){ref-type="fig"}C). To formally address the role of caspase-8 in NAIP5/NLRC4-mediated apoptosis, we infected macrophages with *S*. Typhimurium and quantified cell death in time using SYTOX Green incorporation and western blotting for caspase-1 and caspase-8. As expected, *S*. Typhimurium infection promptly induced caspase-1 maturation ([Figure 3](#fig3){ref-type="fig"}D) and pyroptosis ([Figure 3](#fig3){ref-type="fig"}E) of wild-type (B6) macrophages. Deficiency in caspase-1 and caspase-11 rerouted the cell death response toward apoptosis, as evidenced by efficient caspase-8 maturation and SYTOX Green incorporation that was delayed by 2 hr compared with pyroptotic cells ([Figures 3](#fig3){ref-type="fig"}D and 3E). Notably, deletion of the necroptosis regulator RIPK3 failed to rescue *C1*^*−/−*^*C11*^*−/−*^ macrophages from *S*. Typhimurium-induced apoptosis, whereas further deletion of caspase-8 fully abolished cell death induction ([Figures 3](#fig3){ref-type="fig"}D and 3E). Together, these results establish that NAIP5/NLRC4 agonists induce ASC speck-dependent caspase-8 activation and apoptosis in macrophages lacking caspase-1.Figure 3NAIP5/NLRC4-Induced Apoptosis Is Dependent on ASC and Caspase-8(A and B) Recombinant flagellin was transfected in BMDMs using SLO before bright-field images were acquired (scale bar, 20 μm) (A) and lysates were immunoblotted for caspase-1 and caspase-8 and ASC (B).(C) BMDMs were treated with FlaTox, and confocal micrographs for DAPI (blue), FADD (green), and ASC (red) were taken (scale bar, 10 μm).(D and E) BMDMs of the indicated genotypes were infected with *S*. Typhimurium (50 MOI). Lysates were collected 2 hr post-infection and immunoblotted for caspases 1 and 8 and RIPK3 (D), and cell death was quantified by tracking SYTOX Green incorporation over time (E). Data are shown as mean ± SD from a single representative experiment, with each condition performed in duplicate.(F and G) Primary intestinal epithelial cell (IEC) organoids of the indicated genotypes were stimulated with FlaTox and quantified for PI staining over a 16 hr time window (scale bar, 100 μm). Representative images are shown (F). Observed PI intensity was normalized to organoid surface (G).All data are representative of results from three independent experiments.

Next to macrophages, the NAIP5/NLRC4 inflammasome mediates IL-1β and IL-18 secretion and expulsion of infected intestinal epithelial cells (IECs) in the gut ([@bib41], [@bib45]). However, the role of the NAIP5/NLRC4 inflammasome in IEC death is not clear. Concordant with reported findings ([@bib41]) and paralleling our results in macrophages, we found that FlaTox induced a pyroptotic response in *B6*^*Nlrp1b+*^ IEC organoids, whereas caspase-1-deficient *B6*^*Nlrp1b+*^ IEC organoids responded with apoptosis ([Figure 3](#fig3){ref-type="fig"}F). Notably, FlaTox-induced apoptosis required ASC, as illustrated by micrographs ([Figure 3](#fig3){ref-type="fig"}F) and the absence of FlaTox-induced PI staining in IEC organoids lacking ASC and caspase-1 ([Figure 3](#fig3){ref-type="fig"}F; [Movie S1](#mmc2){ref-type="supplementary-material"}). Cell death was FlaTox-induced because mock-treated IEC organoids of all analyzed genotypes had minimal PI uptake over the studies' incubation periods ([Figure S3](#mmc1){ref-type="supplementary-material"}; [Movie S2](#mmc3){ref-type="supplementary-material"}). Together, these results demonstrate that NLRC4 elicits ASC-dependent caspase-8 activation and apoptosis in caspase-1-deficient macrophages and IEC organoids.

Caspase-1 Enzymatic and Scaffolding Functions Regulate ASC- and Caspase-8-Dependent Apoptosis {#sec2.4}
---------------------------------------------------------------------------------------------

In addition to its enzymatic functions as a protease, caspase-1 might exert non-enzymatic scaffolding functions, as highlighted by the identification of autoinflammatory disease patients expressing caspase-1 variants with reduced or absent catalytic activity ([@bib29], [@bib30]). We generated knockin mice that homozygously express an enzymatically inactive *caspase-1*^*C284A*^ mutant from the endogenous *casp1* locus to distinguish between caspase-1 enzymatic activity and caspase-1 scaffolding as mechanisms that suppress ASC- and caspase-8-dependent apoptosis ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). *Caspase-1*^*C284A/C284A*^ mice were born at Mendelian ratios and were phenotypically normal (data not shown). As expected, *caspase-1*^*C284A*^ was expressed to normal levels in macrophages, but it failed to support FlaTox-induced caspase-1 automaturation ([Figure 4](#fig4){ref-type="fig"}A). Moreover, FlaTox-induced cleavage and secretion of IL-1β and IL-18 were abolished in *caspase-1*^*C284A/C284A*^ macrophages, akin to caspase-1-deficient cells ([Figures 4](#fig4){ref-type="fig"}A--4C). Notably, FlaTox triggered marked caspase-3 and caspase-8 maturation in both caspase-1 knockout and *caspase-1*^*C284A/C284A*^ macrophages ([Figure 4](#fig4){ref-type="fig"}D), in line with their apoptotic appearance ([Figure 4](#fig4){ref-type="fig"}E). However, when tracking DEVD-ase activity over time, we consistently noted reduced caspase-3/7 activity in *caspase-1*^*C284A/C284A*^ macrophages relative to caspase-1-deficient cells ([Figure 4](#fig4){ref-type="fig"}F). FlaTox triggered IEC organoids of *caspase-1*^*C284A/C284A*^ mice to die by apoptosis, which was characterized by slowed PI uptake relative to pyroptotic IEC organoids of wild-type control mice ([Figures 4](#fig4){ref-type="fig"}G and 4H; [Movie S3](#mmc4){ref-type="supplementary-material"}). As expected, cell death was FlaTox-induced because mock-treated IEC organoids of all analyzed genotypes had minimal PI uptake over the studies' incubation periods ([Figure S4](#mmc1){ref-type="supplementary-material"}C; [Movie S4](#mmc5){ref-type="supplementary-material"}). Moreover, FlaTox-induced pyroptosis was blunted in IEC organoids of *NAIP5*^*−/−*^ and *NLRC4*^*−/−*^ mice ([Figures 4](#fig4){ref-type="fig"}G and 4H; [Movie S3](#mmc4){ref-type="supplementary-material"}). Together, these results reveal a dominant role for caspase-1 enzymatic activity, with an accessory contribution of caspase-1 scaffolding functions to suppression of ASC- and caspase-8-mediated apoptosis of macrophages and IEC organoids.Figure 4Caspase-1 Protease and Scaffolding Functions Contribute to Suppression of ASC- and Caspase-8-Dependent Apoptosis(A--E) BMDMs of the indicated genotypes were either primed or not primed with LPS for 3 hr and subsequently stimulated with FlaTox for another 2 hr. Lysates were immunoblotted for caspase-1, caspase-3, and caspase-8, IL-1β; and IL-18 (A and D). The levels of IL-1β (B) and IL-18 (C) were determined in culture supernatants, and bright-field micrographs were taken 2 hr post-stimulation (scale bar, 20 μm) (E). Data are shown as mean ± SD from a single representative experiment of three independent experiments, with each condition performed in triplicate.(F) FlaTox-treated *C1*^*−/−*^*and C1*^*C284A/C284A*^ BMDMs were incubated with CellEvent Caspase-3/7 Green and followed in time by IncuCyte technology. Data are shown as mean ± SD from a single representative experiment of three independent experiments, with each condition performed in duplicate.(G and H) Primary intestinal epithelial organoids of the indicated genotypes were stimulated with FlaTox and followed during 16 hr for PI incorporation (scale bar, 100 μm) (G). Quantification was performed on PI intensity normalized to the surface of the organoid (H). All data are representative of results from at least three independent experiments.

ASC/Caspase-8-Induced Apoptosis Retains Inflammatory Cytokines and Alarmins Intracellularly {#sec2.5}
-------------------------------------------------------------------------------------------

Because caspase-8 was shown to promote maturation and secretion of IL-1β under certain experimental conditions ([@bib1], [@bib11], [@bib31], [@bib37], [@bib54]), we next examined the role of caspase-8 in maturation and secretion of IL-1β and IL-18 from LeTx-stimulated pyroptotic *B6*^*Nlrp1b+*^ and apoptotic *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages. As expected ([@bib51]), secretion of IL-1β from pyroptotic *B6*^*Nlrp1b+*^ cells required prior lipopolysaccharide (LPS) priming for transcriptional upregulation of proIL-1β, whereas proIL-18 is constitutively expressed, and IL-18 secretion by these cells occurred with or without prior LPS priming ([Figures 5](#fig5){ref-type="fig"}A and 5B). In marked contrast, culture supernatants of LeTx-treated *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages were devoid of secreted IL-1β and IL-18 regardless of whether cells were primed with LPS ([Figure 5](#fig5){ref-type="fig"}A and 5B). Immunoblotting showed that, unlike in caspase-1-sufficient *B6*^*Nlrp1b+*^ BMDMs, intracellular IL-1β and IL-18 pools were not converted into mature cytokines in LeTx-treated *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages ([Figure 5](#fig5){ref-type="fig"}C). Similar results were obtained in *B6*^*Nlrp1b+*^ BMDMs and *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages that had been primed with the Toll-like receptor 1/2 (TLR1/2) agonist Pam~3~CSK~4~ or the TLR3 ligand poly(I:C) prior to LeTx challenge ([Figures 5](#fig5){ref-type="fig"}D and 5E). The alarmins HMGB1 and IL-1α were also selectively detected in conditioned medium of pyroptotic *B6*^*Nlrp1b+*^ macrophages ([Figure 5](#fig5){ref-type="fig"}F, G). They were absent from those of LeTx-treated *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages ([Figures 5](#fig5){ref-type="fig"}F and 5G), although HMGB1 was released when cells underwent secondary necrosis (data not shown).Figure 5Cytokines and Alarmins Are Not Released during NLRP1b- and NLRC4-Mediated Apoptosis(A--C) BMDMs of the indicated genotypes were stimulated as depicted. Supernatants were analyzed for IL-1β (A) and IL-18 (B), and lysates were immunoblotted for IL-1β and IL-18 (C).(D and E) BMDMs of the indicated genotypes were stimulated as depicted, and supernatants were analyzed for IL-1β (D) and IL-18 (E) by Luminex assay.(F) *B6*^*Nlrp1b+*^ and *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ BMDMs were stimulated with LeTx, and culture supernatants were immunoblotted for HMGB1 and albumin.(G) LPS-primed or unprimed *B6*^*Nlrp1b+*^ and *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ BMDMs were stimulated with LeTx. The supernatant was analyzed for IL-1α (G). Data are shown as mean ± SD from a single representative experiment of three experiments, with each condition performed in triplicate.(H--M) BMDMs from *B6*, *NLRC4*^*−/−*^, *ASC*^*−/−*^, and *C1*^*−/−*^*C11*^*−/−*^ mice were left unprimed (H, J, and L) or primed (I, K, and M) with LPS for 3 hr and subsequently infected with *S*. typhimurium (MOI 50). The supernatant was used to determine the levels of IL-1β (H and I), IL-18 (J and K), and IL-1α (L and M) by Luminex. Data are shown as mean ± SD from a single representative experiment of three experiments, with each condition performed in triplicate.

As expected ([@bib4], [@bib51]), *S.* Typhimurium infection of wild-type (B6) BMDMs triggered significant secretion of IL-1β, which was partially dependent on ASC ([Figure 5](#fig5){ref-type="fig"}H). Prior LPS treatment significantly increased secreted IL-1β levels from wild-type and *ASC*^*−/−*^ macrophages at both 1 and 3 hr post-infection ([Figure 5](#fig5){ref-type="fig"}I). In sharp contrast, *NLRC4*^*−/−*^ and *C1*^*−/−*^*C11*^*−/−*^ macrophages failed to secrete IL-1β regardless of whether they had been prestimulated with LPS ([Figure 5](#fig5){ref-type="fig"}H, I). IL-18 also was selectively secreted by *S*. Typhimurium-infected wild-type and *ASC*^*−/−*^ macrophages that underwent pyroptosis but not by apoptotic *C1*^*−/−*^*C11*^*−/−*^ macrophages ([Figures 5](#fig5){ref-type="fig"}J and 5K). In agreement with a pre-existing pool of proIL-18 being present in naive macrophages, IL-18 secretion from wild-type macrophages was already significant 1 hr post-infection, and it did not require prior LPS priming ([Figures 5](#fig5){ref-type="fig"}J and 5K). We similarly found that the alarmin IL-1α was released extracellularly by pyroptotic wild-type and *ASC*^*−/−*^ macrophages but not by *S*. Typhimurium-infected *NLRC4*^*−/−*^ and *C1*^*−/−*^*C11*^*−/−*^ macrophages that do not undergo pyroptosis ([Figures 5](#fig5){ref-type="fig"}L and 5M). Together, these results show that pyroptotic cell death is associated with release of inflammatory cytokines and chemotactic alarmins, whereas ASC/caspase-8-mediated apoptosis largely retains these inflammatory mediators intracellularly.

c-FLIP Upregulation Suppresses Caspase-8 Activation and Apoptosis Downstream of ASC Speck Assembly {#sec2.6}
--------------------------------------------------------------------------------------------------

While examining possible reasons for the apparent lack of IL-1β and IL-18 maturation and alarmin secretion from LeTx-treated *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages, we found that LPS priming inhibited LeTx-induced caspase-8 activation ([Figure 6](#fig6){ref-type="fig"}A) and apoptosis induction ([Figure 6](#fig6){ref-type="fig"}B), which we confirmed to occur in LeTx-treated *BALB/c-C1*^*−/−*^*C11*^*−/−*^ macrophages as well ([Figures S5](#mmc1){ref-type="supplementary-material"}A and S5B). LPS specifically inhibited LeTx-induced caspase-8 activation because it failed to inhibit LeTx-induced caspase-1 activation and pyroptosis in *B6*^*Nlrp1b+*^ ([Figures 6](#fig6){ref-type="fig"}A and [S6](#mmc1){ref-type="supplementary-material"}B) and BALB/c ([Figures S5](#mmc1){ref-type="supplementary-material"}A and S5B) macrophages. Interestingly, preventing *de novo* protein translation with cycloheximide restored LeTx-induced caspase-8 activation ([Figure 6](#fig6){ref-type="fig"}C) and apoptosis ([Figure S5](#mmc1){ref-type="supplementary-material"}C) in LPS-primed *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages. The TLR1/2 agonist Pam~3~CSK~4~ and the TLR3 ligand poly(I:C) also inhibited LeTx-induced caspase-8 maturation and apoptosis ([Figure 6](#fig6){ref-type="fig"}D; [Figure S5](#mmc1){ref-type="supplementary-material"}D), suggesting that *de novo* protein synthesis by both the MyD88- and TRIF-dependent TLR signaling axes interfered with LeTx-induced caspase-8 activation. Notably, LPS priming prevented caspase-8 activation and apoptosis downstream of ASC speck formation ([Figures 6](#fig6){ref-type="fig"}E--6G). Together, these results implied that TLR signaling upregulated a factor that inhibited LeTx-induced apoptosis by blocking caspase-8 activation in ASC specks. c-FLIP is a nuclear factor κB (NF-kB)-regulated protein that is known to modulate caspase-8 activation ([@bib36]). In agreement, we only detected significant expression of known c-FLIP isoforms (named c-FLIP~R~ and c-FLIP~L~) in *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages when cells had been prestimulated with LPS ([Figure 6](#fig6){ref-type="fig"}H). Notably, LPS-primed macrophages expressed full-length c-FLIP~L~, which appeared to undergo cleavage into a 43-kDa product upon LeTx challenge ([Figure 6](#fig6){ref-type="fig"}H), reminiscent of its reported cleavage by caspase-8 upon death receptor engagement ([@bib36]). The c-FLIP~L~-caspase-8 heterodimer was shown to restrict caspase-8-mediated cleavage to locally available substrates, suppressing apoptosis induction while still allowing non-apoptotic caspase-8 signaling. We observed diminished LeTx-induced cleavage of the caspase-8 substrates caspase-3 and RIP1 in LPS-primed *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages ([Figure 6](#fig6){ref-type="fig"}I), suggesting that these substrates may not be readily accessible to ASC speck-confined caspase-8. We employed siRNA-mediated knockdown of c-FLIP expression to further characterize the role of c-FLIP in the modulation of LeTx-induced caspase-8 activation and apoptosis induction. Unlike scrambled siRNA controls, c-FLIP-targeting siRNAs (individually and pooled) efficiently reduced c-FLIP expression in Pam~3~CSK~4~-stimulated *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages ([Figure 6](#fig6){ref-type="fig"}J). Moreover, c-FLIP knockdown enabled "spontaneous" LPS-induced caspase-8 activation and apoptosis in *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages, whereas cells pretreated with control siRNAs failed to induce these responses ([Figures S5](#mmc1){ref-type="supplementary-material"}E and S5F and data not shown). Spontaneous LPS-induced caspase-8 activation was likely TRIF-mediated because Pam~3~CSK~4~ priming did not facilitate caspase-8 activation following c-FLIP downregulation ([Figures 6](#fig6){ref-type="fig"}K and 6L). However, c-FLIP downregulation did rescue LeTx-induced caspase-8 activity in Pam~3~CSK~4~-primed macrophages ([Figures 6](#fig6){ref-type="fig"}K and 6L), confirming the critical role of TLR-induced c-FLIP upregulation in modulating ASC- and caspase-8-dependent apoptosis.Figure 6TLR-Induced Upregulation of c-FLIP Expression Inhibits LeTx-Induced Caspase-8 Activation Downstream of ASC Speck Formation(A and B) BMDMs of the indicated genotypes were stimulated as depicted, lysates were immunoblotted for caspase-1 and caspase-8 (A), and bright-field micrographs were taken (scale bar, 20 μm) (B).(C) Where indicated, *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ BMDMs were pretreated with cycloheximide (CHX) prior to stimulation with LPS and LeTx for 3 hr, and lysates were immunoblotted for caspase-8.(D) BMDMs of the indicated genotypes were primed with Pam~3~CSK~4~ or poly(I:C) before treatment with LeTx for 3 hr. Lysates were immunoblotted for caspase-1 and caspase-8.(E--G) *B6*^*Nlrp1b+*^ and *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ BMDMs were stimulated as indicated before confocal micrographs of DAPI (blue), caspase-8 (green), and ASC (red) staining were taken (scale bar, 10 μm) (E), and ASC specks were quantified over multiple representative confocal micrographs (F). Crosslinked ASC oligomers were isolated, and lysates were immunoblotted for ASC (G).(H) *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ BMDMs were stimulated as indicated, and lysates were immunoblotted for c-FLIP and β-actin.(I) Lysates *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ BMDMs were immunoblotted for the indicated proteins.(J--L) Pam~3~CSK~4~-stimulated *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ BMDMs were transfected with scrambled and c-FLIP siRNAs before lysates were probed for c-FLIP and β-actin expression (J). Pam~3~CSK~4~-stimulated BMDMs were treated as depicted before lysates were immunoblotted for caspase-8 (K), and analyzed for DEVD-amc conversion (L).Data are shown as mean ± SD from a single representative experiment of at least three experiments.

c-FLIP Suppresses *S.* Typhimurium-Induced Caspase-8 Activation and Apoptosis Induction {#sec2.7}
---------------------------------------------------------------------------------------

*S.* Typhimurium is a pathogen that stimulates TLR4 while also engaging the NLRC4 inflammasome. We therefore addressed whether c-FLIP was upregulated in *S.* Typhimurium-infected macrophages and whether this also affected NLRC4-induced apoptosis. Consistent with our earlier findings, c-FLIP expression was below the detection limit in mock-treated *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages, but expression of both the c-FLIP~L~ and c-FLIP~R~ isoforms was induced by *S.* Typhimurium infection ([Figure 7](#fig7){ref-type="fig"}A). As before, prior LPS priming further upregulated the expression levels of these c-FLIP isoforms ([Figure 7](#fig7){ref-type="fig"}A). LPS priming significantly reduced caspase-8 maturation in *C1*^*−/−*^*C11*^*−/−*^ and *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ cells, whereas it had no effect on *S.* Typhimurium-induced caspase-1 maturation in *B6* ([Figure 7](#fig7){ref-type="fig"}B) and *B6*^*Nlrp1b+*^ macrophages ([Figure S6](#mmc1){ref-type="supplementary-material"}A). Priming with the TLR1/2 agonist Pam~3~CSK~4~ also markedly attenuated caspase-8 activation upon introduction of *S.* Typhimurium flagellin in the cytosol of *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ macrophages ([Figure 7](#fig7){ref-type="fig"}C). Unlike scrambled control siRNAs, c-FLIP-targeting siRNAs efficiently rescued cytosolic flagellin-induced caspase-8 activation in Pam~3~CSK~4~-primed macrophages ([Figure 7](#fig7){ref-type="fig"}C), demonstrating that c-FLIP upregulation in TLR-primed macrophages suppresses NLRC4-mediated caspase-8 activation.Figure 7NLRC4-Induced Apoptosis Is Inhibited by LPS Priming(A) Naive and LPS-primed *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ BMDMs were infected with *S*. Typhimurium (50 MOI) for 2 hr before lysates were immunoblotted for c-FLIP and β-actin.(B) BMDMs of the indicated genotypes were treated as depicted before lysates were immunoblotted for caspase-1 and caspase-8.(C) *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ BMDMs were transfected with scrambled control and c-FLIP-targeting siRNAs before stimulation with Pam~3~CSK~4~ (Pam) and SLO-mediated cytosolic delivery of recombinant flagellin. Lysates were immunoblotted for caspase-8.(D--G) BMDMs of the indicated genotypes were left unprimed (●) or primed with LPS (▪) for 3 hr before infection with *S*. Typhimurium (50 MOI). Supernatants were analyzed for LDH activity (dash line), and annexin V/PI staining (full line) was performed by FACS. Data are shown as mean from a single representative experiment out of two independent experiments, with each condition performed in triplicate.(H) Schematic representation of cell death signaling by the CARD-based inflammasome sensors NLRP1b and NLRC4. Engagement of NLRP1b or NLRC4 leads to caspase-1 maturation and induction of pyroptosis with release of alarmins and inflammatory cytokines, resulting in inflammation. In the absence of caspase-1, ASC specks serve as cytosolic platforms for efficient caspase-8 activation, which drives apoptosis characterized by the absence of alarmin and inflammatory cytokine release. TLR-mediated c-FLIP upregulation potently impedes caspase-8-dependent apoptosis but not pyroptosis.

To further address the role of TLR-induced c-FLIP upregulation in the regulation of NLRC4-mediated cell death responses, we compared cell death levels of naive and LPS-primed macrophages following *S.* Typhimurium infection. Apoptotic cells were defined as cells that became positive for annexin V in the absence of LDH release, whereas pyroptosis was associated with simultaneous annexin V staining and LDH release. Indicative of pyroptosis induction, *S.* Typhimurium-infected wild-type (*B6*) and *ASC*^*−/−*^ macrophages concomitantly stained positive for annexin V and released LDH when analyzed 1 and 3 hr post-infection ([Figures 7](#fig7){ref-type="fig"}D and 7E; [Figures S6](#mmc1){ref-type="supplementary-material"}B and S6C). As expected, *NLRC4*^*−/−*^ macrophages were largely protected from *S.* Typhimurium-induced cell death at these time points ([Figure 7](#fig7){ref-type="fig"}F). In contrast, infected *C1*^*−/−*^*C11*^*−/−*^ macrophages responded with delayed induction of apoptosis, as evidenced by annexin V positivity in the absence of LDH activity ([Figure 7](#fig7){ref-type="fig"}G; [Figures S6](#mmc1){ref-type="supplementary-material"}B and S6C). Notably, LPS priming prior to *S.* Typhimurium infection inhibited apoptosis in infected *C1*^*−/−*^*C11*^*−/−*^ macrophages, but not pyroptosis, in wild-type and *ASC*^*−/−*^ macrophages ([Figures 7](#fig7){ref-type="fig"}D, 7E, and 7G; [Figures S6](#mmc1){ref-type="supplementary-material"}B and S6C). Together, these results demonstrate that NLRC4-induced apoptosis is sensitive to c-FLIP-mediated inhibition whereas pyroptosis is not.

Discussion {#sec3}
==========

Pyroptosis is a non-homeostatic, lytic regulated cell death mode that is increasingly recognized as a critical host defense mechanism for fighting microbial pathogens ([@bib15]). In addition to trapping intracellular pathogens and depriving them of their replicative niches, pyroptotic cell rupture is thought to release IL-1β, IL-18, and the nuclear alarmin HMGB1 to attract and stimulate neutrophils and other immune cells at the infectious locus ([@bib19], [@bib26], [@bib28], [@bib46]). A recent single-cell analysis of inflammasome activation supported this notion by demonstrating that IL-1β-secreting macrophages corresponded to pyroptotic cells ([@bib28]). Consequently, many bacterial and viral pathogens express virulence factors that suppress inflammasome activation ([@bib23]). Under conditions of chronic inflammation, however, pyroptosis is likely to be detrimental to the host. Although this hypothesis awaits empirical validation, genetic deletion of caspase-1 has been shown to be significantly more effective than targeting downstream IL-1β and IL-18 signaling in controlling early perinatal lethality and inflammatory pathology of Nlrp3 knockin mice that model Muckle-Wells syndrome-associated disease ([@bib5]). Moreover, recent studies identified autoinflammatory disease patients with autosomal dominant NLRC4 and NLRP1 mutations ([@bib3], [@bib6], [@bib10], [@bib18], [@bib20], [@bib42], [@bib55], [@bib59]). The clinical presentation of NLRC4- and NLRP1-associated autoinflammatory diseases may vary considerably, but IL-1β, IL-18, and pyroptosis are thought to contribute importantly to the etiology of these diseases. Unlike during pyroptosis, however, apoptotic cells are orderly packed in "apoptotic bodies" for efferocytosis by neighboring cells and professional phagocytes without spilling immunogenic factors in the extracellular space. Therefore, steering cell death responses away from pyroptosis and toward apoptotic cell death may represent an attractive approach to treat IL-1β/IL-18- and alarmin-induced inflammation and tissue damage in NLRP1- and NLRC4-associated autoinflammation and other chronic inflammatory diseases ([Figure 7](#fig7){ref-type="fig"}H).

Here we showed that the failure to activate caspase-1 following engagement of NLRP1b and NLRC4 results in caspase-8-driven apoptosis instead of pyroptosis. In support of our model, *S.* Typhimurium infection has been shown previously to trigger apoptosis in caspase-1/11-deficient macrophages, although the molecular mechanisms involved have not been fully explored ([@bib40]). Our analysis of knockin mice that express a catalytically inactive caspase-1^C284A^ mutant revealed a dominant role for caspase-1 protease activity and an accessory contribution of caspase-1 scaffolding for suppression of caspase-8 activation. Importantly, genetic deletion of ASC abolished NLRP1b- and NLRC4-induced apoptosis, thus establishing ASC specks as *bona fide* intracellular platforms for caspase-8-mediated apoptosis on par with death receptor-induced caspase-8-activating platforms. In agreement, we detected low levels of active caspase-8 in ASC specks of pyroptotic macrophages and showed that ASC specks of apoptotic macrophages contained markedly higher levels of active caspase-8. We further showed that TLRs stimulated *de novo* synthesis of c-FLIP, which inhibited ASC/caspase-8-mediated apoptosis but not inflammasome-induced pyroptosis. This implies that, in cells failing caspase-1 engagement, c-FLIP upregulation serves as a second checkpoint for modulating inflammasome-associated caspase-8 activation and apoptosis induction ([Figure 7](#fig7){ref-type="fig"}H). Moreover, unlike during pyroptosis, inflammasome-dependent cytokines and alarmins were retained intracellularly during NLRP1b- and NLRC4-elicited apoptosis until cells became secondarily necrotic. Overall, this work demonstrates that CARD-based inflammasome sensors induce c-FLIP-sensitive, non-inflammatory, ASC/caspase-8-dependent apoptosis when caspase-1 engagement fails and suggests that switching pyroptosis to ASC/caspase-8-mediated apoptosis might suppress inflammatory pathology in patients with gain-of-function mutations in NLRP1 and NLRC4 as well as in other patients suffering from chronic inflammation.

Experimental Procedures {#sec4}
=======================

Mice {#sec4.1}
----

*B6*^*Nlrp1b+*^ ([@bib2]), *C1*^*−/−*^*C11*^*−/−*^ ([@bib22]), *ASC*^*−/−*^ ([@bib33]), *Nlrc4*^−/−^ ([@bib33]), *C1*^*−/−*^ ([@bib48]), *C8*^−/−^*RIPK3*^−/−^ ([@bib38]) and *Naip5*^*−/−*^ ([@bib27]) mice on a C57BL/6 background have been described previously. *C1*^*−/−*^*C11*^*−/−*^ mice have also been backcrossed to the BALB/c genetic background for 7 generations. *C1*^*C284A/C284A*^ mice were produced by targeting exon 5 of *Casp1* by CRISPR-Cas9 technology using the single guide RNA (sgRNA) 5′ CCGTGGAGGTAAGTGCTGA 3′ in C57BL/6 zygotes. The single-stranded DNA (ssDNA) sequence to introduce the C284A mutation was 5′ GATGAACACTTTGAAGTGCCCAAGCTTGAAAGACAAGCCCAAGGTGATCATTATTCAGGCCGCCCG TGGAGGTAAGTGCTGATTGTTTAAAATAACAGGGCATTCCCATTGAGACTTTATCATTTATAGATAGAGAGTACTCTT 3′. A silent HaeIII restriction site was created to genotype the mice. C57BL/6J and BALB/c mice were originally purchased from Charles River Laboratories and bred in-house. Mice of any sex and age were used for production of BMDMs and IECs. Animals were housed in individually ventilated cages under specific pathogen-free conditions, and all studies were conducted under protocols approved by the Ghent University Committee on the Use and Care of Animals.

Macrophage Differentiation and Stimulation {#sec4.2}
------------------------------------------

BMDMs were generated by culturing mouse bone marrow cells in L-cell-conditioned Iscove's Modified Dulbecco's Medium (IMDM) supplemented with 10% fetal bovine serum (FBS), 1% non-essential amino acids, and 1% penicillin-streptomycin for 6 days in a humidified atmosphere containing 5% CO~2~. BMDMs were seeded in 12-well plates and, the next day, either left untreated or stimulated with 500 ng/mL ultrapure LPS from *Salmonella minnesota* (InvivoGen), 1 μg/mL Pam~3~CSK~4~ (InvivoGen), or 1 μg/mL poly(I:C) (InvivoGen) for 3 hr prior to treatment with anthrax PA (500 ng/mL, Quadratech) and wild-type or proteolytically inactive LF (250 ng/mL, Quadratech). In some experiments, BMDMs were pretreated with the caspase-8 inhibitor z-IETD-fmk (50 μM, R&D Systems) or the proteasome inhibitor MG132 (10 μM, Calbiochem) for 30 min prior to LeTx incubation. Alternatively, BMDMs were pretreated with the translation inhibitor cycloheximide (CHX, 50 ng/mL, Sigma-Aldrich) for 15 min prior to LPS priming (500 ng/mL), followed by LeTx treatment. Otherwise, 10 min pretreatment with trans-activator of transcription of HIV-1 (TAT)-CrmA (2 μM, purified as described previously; [@bib21]) was performed prior to LeTx stimulation. To stimulate the NLRC4 inflammasome, BMDMs were either primed or not primed with 500 ng/mL LPS for 3 hr, followed by *S.* Typhimurium infection (MOI 50) for 1 hr and 3 hr, respectively. Gentamycin (50 μg/mL, 10131-027, Life Technologies) was added 1 hr post-infection to kill extracellular bacteria. Alternatively, recombinant *S.* Typhimurium flagellin (fliC, 5 μg/mL) produced in *E. coli* ([@bib50]) was delivered in the cytosol using SLO (25 μg/mL, S5265-25KU, Sigma) as described before ([@bib25]). In other experiments, cells were treated with anthrax PA (500 ng/mL, Quadratech) and 1 μg/mL LFn-FlaA ([@bib58]).

Primary Intestinal Epithelial Organoids {#sec4.3}
---------------------------------------

Primary intestinal epithelial organoids were grown as described before ([@bib44]). Briefly, the small intestine was flushed and cut into small pieces that were dissociated in PBS containing 2 mM EDTA for 30 min at 4°C. After extensive washing, the isolated crypts were pelleted and mixed with 50 μL of Matrigel (Corning) and put in a 24-well plate. After polymerization of the Matrigel, complete culture medium containing advanced DMEM/F12 (Gibco) supplemented with B27 supplement (0.02%, Invitrogen), N2 supplement (0.1%, Invitrogen), N-acetylcysteine (0.0025%, Sigma-Aldrich), mouse epidermal growth factor (mEGF; 0.001%, Invitrogen), and conditioned Rspondin and mNoggin medium. Organoids were seeded and imaged in an 8-well chamber (iBidi). Cell death was induced just before imaging and was monitored by an increase in PI positivity. Live-cell imaging was performed on an Axio Observer Z1 (Zeiss, Germany) equipped with a CSU-X1 spinning-disk head (Yokogawa) and AxioCam MRm (Zeiss), with a EC Plan-Neofluar 10× dry objective (numerical aperture \[NA\] 0.30). Images were acquired every 15 min for 16 hr. Data analysis and image reconstruction were performed with ImageJ (NIH).

Western Blotting {#sec4.4}
----------------

Cell lysates were incubated in cell lysis buffer (20 mM Tris HCl \[pH 7.4\], 200 mM NaCl, and 1% NP-40) and denatured in Laemmli buffer. Protein samples were boiled at 95°C for 10 min and separated by SDS-PAGE. Separated proteins were transferred to polyvinylidene fluoride (PVDF) membranes. Blocking, incubation with antibody, and washing of the membrane were done in PBS supplemented with 0.05% or 0.2% Tween 20 (v/v) and 3% or 1% (w/v) non-fat dry milk. Immunoblots were incubated overnight with primary antibodies against caspase-1 (AG-20B-0042-C100, Adipogen), caspase-8 (ALX-804-447-C100, 1G12, Enzo Life Sciences; 8592S, D5B2, Cell Signaling Technology), caspase-3 (9662, Cell Signaling Technology; 9664S, 5A1E, Cell Signaling Technology), ASC (AG-25B-0006, Adipogen), RIPK3 (ADI-905-242-100, Enzo Life Sciences), RIPK1 (610458, BD Biosciences), IL-1β (GTX74034, GeneTex), IL-18 (5180R-100, BioVision Technologies), c-FLIP (AG-20B-0005-C100, Adipogen), HMGB1 (ab18256, Abcam), albumin (sc-46291, Santa Cruz Biotechnology), and β-actin (sc-47778-HRP, Santa Cruz Biotechnology). Horseradish peroxidase-conjugated goat anti-mouse (115-035-146, Jackson ImmunoResearch Laboratories), anti-rabbit (111-035-144, Jackson ImmunoResearch Laboratories), or anti-rat (112-035-143, Jackson ImmunoResearch Laboratories) secondary antibody was used to detect proteins by enhanced chemiluminescence (Thermo Scientific).

Cell Death Kinetic Measurements {#sec4.5}
-------------------------------

A plate-based fluorometric assay (FLUOstar, Omega BMG Labtech) was used to quantify cell permeabilization (5 μM SYTOX Green) and caspase-3 activation (10 μM Asp-Glu-Val-Asp-7-amino-4-methylcoumarin \[DEVD-amc\]). Briefly, stimulated cells were incubated in the presence of SYTOX Green and DEVD-amc in a CO~2~- and temperature-controlled environment that allowed measurement of fluorescent signals over a time span of 3 hr. The maximum slope of fluorescence over time (ΔF/minute) was used as a measure for cell death. Alternatively, the IncuCyte Zoom system (Essenbio) was used to acquire and analyze cell death rates over a period of time. Caspase-3/7 activation was detected using CellEvent Caspase3/7 Green substrate (Invitrogen) according to the manufacturer's instructions.

siRNA Transfection {#sec4.6}
------------------

Viromer Green (Lipocalyx) was used according to the manufacturer's instructions. The siRNAs directed against c-FLIP (SR400039) and caspase-8 (SR415523) were purchased from OriGene with a scrambled control present. After 24 hr of siRNA transfection, Pam~3~CSK~4~ (InvivoGen) or ultrapure LPS from *Salmonella minnesota* (InvivoGen) priming for 3 hr was followed by LeTx stimulation for another 3 hr. Alternatively, after 24 hr of siRNA transfection, purified fliC (5 μg/mL) was delivered in the cytosol using SLO for another 3 hr.

Fluorescence and Confocal Microscopy {#sec4.7}
------------------------------------

*B6*^*Nlrp1b+*^, *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^, and *B6*^*Nlrp1b+*^*C1*^*−/−*^*C11*^*−/−*^ASC^−/−^ macrophages grown on coverslips were either left untreated (mock) or stimulated with LeTx for 105 min, fixed in 4% paraformaldehyde, and stained with antibodies against ASC (04-147, Millipore; pAL177 AG-25B-0006, Adipogen) and caspase-8 (8592S, D5B2, Cell Signaling Technology) or FADD (sc-6036, Santa Cruz Biotechnology). The secondary antibodies anti-mouse Alexa Fluor 594, anti-rabbit Alexa Fluor 488, or anti-goat Alexa Fluor 488 (Invitrogen) were used. Slides were mounted in ProLong Gold Antifade reagent with DAPI (Life Technologies). Confocal micrographs were taken on an Olympus microscope using a 60× objective lens. Alternatively, fixed cells were imaged on a Zeiss LSM780 confocal microscope (Zeiss, Germany) using a Plan-Apochromat 40× (NA 1.4) oil objective. The pinhole was set at 1 Airy unit (the theoretical point with optimal collection of the most "real" signal, with use of a pinhole to physically filter out most scattered light), and 4× frame averaging was applied to reduce noise.

Cytokine Analysis {#sec4.8}
-----------------

Cytokine levels in cell culture medium were determined by magnetic bead-based multiplex assay using Luminex technology (Bio-Rad) according to the manufacturer's instructions.

Cell Death Measurements {#sec4.9}
-----------------------

Cell death levels were determined by LDH assay (Promega) in culture medium. Alternatively, annexin V (BD Pharmingen) and PI staining on cells was performed according to the manufacturer's instructions. Flow cytometry was used to measure stained cells, and data were analyzed with FlowJo software.

ASC Oligomer Analysis {#sec4.10}
---------------------

ASC oligomers were purified as described before ([@bib8]). Briefly, culture supernatants were discarded, and cells were lysed in 500 μL lysis buffer (20 mM potassium; 2-\[4-(2-hydroxyethyl)piperazin-1-yl\] ethanesulfonic acid; hydroxide \[HEPES-KOH\] \[pH 7.5\], 150 mM KCl, 1% NP40, 0.1 mM PMSF, and protease inhibitor cocktail) on ice. Lysates were prepared by syringing 10 times, followed by centrifugation for 10 min at 6,000 rpm at 4°C. Pellets were washed twice with PBS and resuspended in 500 μL PBS, followed by crosslinking with 2 mM fresh disuccinimidyl suberate (DSS) for 30 min at room temperature. Subsequently, cells were pelleted by centrifugation at 6,000 rpm for 10 min at 4°C, and pellets were resuspended in 60 μL 1× SDS buffer, followed by immunoblotting for ASC.

*In Vitro* Protease Activity Assays {#sec4.11}
-----------------------------------

*In vitro* caspase-1 activity was determined by incubating 1 IU recombinant mouse caspase-1 (1181-100, BioVision Technologies) with 50 μM fluorogenic caspase-1 substrate peptide Acetyl-Trp-Glu-His-Asp-7-Amino-4-methylcoumarin (Ac-WEHD-amc) (ALX-260-057-M005, Enzo Life Sciences) in 200 μL cell free system (CFS) buffer (10 mM HEPES \[pH 7.4\], 220 mM mannitol, 68 mM sucrose, 2 mM NaCl, 2.5 mM KH~2~PO~4~, 0.5 mM EGTA, 2 mM MgCl~2~, 0.5 mM sodium pyruvate, 0.5 mM L-glutamine, and 10 mM DTT). The release of fluorescent 7-amino-4-methylcoumarin in the presence of the indicated concentrations of the proteasome inhibitor MG132 (474791, Calbiochem), DMSO (Sigma-Aldrich), or the caspase-1 inhibitor Acetyl-Tyr-Val-Ala-Asp - chloromethylketone (Ac-YVAD-cmk) (ALX-260-028-M001, Enzo Life Sciences) was measured for 20 min at 1-min intervals by fluorometry (excitation at 360 nm and emission at 460 nm) on a microplate fluorescence reader (Bio-Tek Instruments), and the maximal rate of increase in fluorescence was calculated (ΔF/minute). The same was done for caspase-8 activity by incubating 100 ng recombinant mouse caspase-8 (ALX-201-163-C020, Enzo Life Sciences) with 50 μM fluorogenic caspase-8 substrate peptide Acetyl-Ile-Glu-Thr-Asp-7-Amino-4-methylcoumarin (Ac-IETD-amc) (ALX-260-042-M005, Enzo Life Sciences) in 50 μL CFS buffer in the presence of MG132, DMSO, or z-IETD-fmk (FMK0F07, R&D Systems). To determine anthrax LF activity, 50 nM recombinant LF (Quadratech) was incubated with 2 mM anthrax LF substrate III (176904, Calbiochem) in the presence of MG132, DMSO, or In-2-LF (176901, Calbiochem).
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